【発明の名称】抗炎症剤としての置換ピリジン化合物

Japanese Patent JP2001522834

A

Selected novel substituted pyridine compounds are effective for prophylaxis and treatment of diseases, such as TNF- alpha , IL-1 beta , IL-6 and/or IL-8 mediated diseases, and other maladies, such as pain and diabetes. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving inflammation, pain, diabetes, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

JP2002097138	MCH(MELANIN-CONCENTRATING HORMONE) ANTAGONIST
JP2005501030	Organometallic antitumor agent

Mantro, Nathan Bee
Syuractor, Stephen Tay
Ji-yo Ji, Ji Young Ai

JP2000520418A

November 20, 2001

November 04, 1998

Click for automatic bibliography generation  

Amjien Incorporated

A61K31/44; A61K31/4418; A61K31/4427; A61K31/443; A61K31/4433; A61K31/4436; A61K31/4439; A61K31/444; A61K31/496; A61P1/04; A61P3/10; A61P3/14; A61P9/02; A61P9/10; A61P11/00; A61P11/06; A61P17/00; A61P17/06; A61P19/02; A61P19/06; A61P19/08; A61P19/10; A61P21/06; A61P25/28; A61P27/02; A61P27/16; A61P29/00; A61P31/12; A61P31/18; A61P35/00; A61P35/02; A61P37/06; A61P37/08; C07D213/73; C07D213/75; C07D213/82; C07D401/12; C07D405/12; C07D409/12; C07D413/12; C07D417/12; C07D471/04; (IPC1-7): C07D213/75; A61K31/44; A61K31/443; A61K31/4436; A61K31/4439; A61K31/444; A61K31/496; A61P1/04; A61P3/10; A61P3/14; A61P9/02; A61P9/10; A61P11/00; A61P11/06; A61P17/00; A61P17/06; A61P19/02; A61P19/06; A61P19/08; A61P19/10; A61P21/06; A61P25/28; A61P27/02; A61P27/16; A61P29/00; A61P31/12; A61P31/18; A61P35/00; A61P35/02; A61P37/06; A61P37/08; C07D401/12; C07D405/12; C07D409/12; C07D413/12; C07D417/12; C07D471/04

Yoshio Kawaguchi (3 outside)

Previous Patent: JP2001522833

Next Patent: フェニル−アルキル−イミダゾール型のＨ３レセプターリガンド